As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...
Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...
AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's ...
insitro has acquired Israeli AI therapeutics company CombinAbleAI and launched its TherML platform, creating an end-to-end, ...
Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and ...
TAMEST (Texas Academy of Medicine, Engineering, Science and Technology) and Lyda Hill Philanthropies today announced the ...
Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...
Zacks Investment Research on MSN
Three genomics stocks worth tracking this year
An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...
Sarepta Therapeutics, Inc. reported FY25 revenue of $1.86B, maintains a robust cash position of $953.8M. Click here to read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback